Search results
Objective Capital Management LLC Purchases New Position in JPMorgan Active Growth ETF...
ETF DAILY NEWS· 5 days agoObjective Capital Management LLC acquired a new position in JPMorgan Active Growth ETF...
Gateway - Quartz
Quartz· 4 days agoNovo Nordisk responded this week to the Federal Trade Commission’s (FTC) suggestion that it filed ‘junk’ patents to prevent competition and raise prices. Moderna stock surged ...
Covid-19 Pharma Stars Continue Their Quest To Set New Standards In Cancer Treatment
Benzinga via Yahoo Finance· 4 days agoAstraZeneca PLC (NASDAQ: AZN) kicked off the week by receiving approval from the U.S. Food and Drug...
Gateway - Quartz
Quartz· 4 days agoHealthcare companies including Ro and Eli Lilly are introducing online supply trackers to help patients navigate ongoing GLP-1 drug shortages. Moderna says it is in talks ...
SageView Advisory Group LLC Makes New $1.12 Million Investment in Norfolk Southern Co. (NYSE:NSC)
ETF DAILY NEWS· 5 days agoSageView Advisory Group LLC acquired a new position in shares of Norfolk Southern Co. (NYSE:NSC –...
SageView Advisory Group LLC Buys 5,345 Shares of Diageo plc (NYSE:DEO)
ETF DAILY NEWS· 5 days agoSageView Advisory Group LLC lifted its position in Diageo plc (NYSE:DEO – Free Report) by 230.0% in...
Objective Capital Management LLC Raises Stake in Vanguard Small-Cap ETF (NYSEARCA:VB)
ETF DAILY NEWS· 5 days agoObjective Capital Management LLC grew its position in shares of Vanguard Small-Cap ETF (NYSEARCA:VB – Free Report) by 7.7% during the fourth quarter, Holdings Channel reports. The institutional ...
Biotech Stock Roundup: ITCI Up on Study Data, ZNTL, OVID Down on Updates & More News
Zacks via Yahoo Finance· 2 days agoIntra-Cellular Therapies (ITCI) and Zentalis Pharmaceuticals, Inc. (ZNTL) are in the spotlight...
Drug names: How companies and regulators come up with hundreds of new names every year
Quartz· 3 days agoEverything you need to know about the art and science of drug naming in five minutes or less,...
Gateway - Quartz
Quartz· 3 days agoThe U.S. government is close to finalizing a deal to fund a late-stage trial of Moderna’s mRNA H5N1 bird flu vaccine, as the virus continues to spread rapidly among poultry ...